Validation of Human ApoB and ApoAI Immunoturbidity Assays for Non-human Primate Dyslipidemia and Atherosclerosis Research-Reference-Cited by-同舟云学术

Validation of Human ApoB and ApoAI Immunoturbidity Assays for Non-human Primate Dyslipidemia and Atherosclerosis Research

Published:2011-03-11 Issue:3 Volume:4 Page:373-383
ISSN:1937-5387
Container-title:Journal of Cardiovascular Translational Research
language:en
Short-container-title:J. of Cardiovasc. Trans. Res.

Author:

Chen Zhu,Strack Alison M.,Stefanni Alice C.,Chen Ying,Wu Weizhen,Pan Yi,Urosevic-Price Olga,Wang Li,McLaughlin Theresa,Geoghagen Neil,Lassman Michael E.,Roddy Thomas P.,Wong Kenny K.,Hubbard Brian K.,Flattery Amy M.

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12265-011-9264-4.pdf

Reference38 articles.

1. Kathiresan, S., Otvos, J. D., Sullivan, L. M., Keyes, M. J., Schaefer, E. J., Wilson, P. W., et al. (2006). Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation, 113, 20–29.

2. Barter, P. J., Ballantyne, C. M., Carmena, R., Castro Cabezas, M., Chapman, M. J., Couture, P., et al. (2006). Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. Journal of Internal Medicine, 259, 247–258.

3. Contois, J. H., McNamara, J. R., Lammi-Keefe, C. J., Wilson, P. W., Massov, T., & Schaefer, E. J. (1996). Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clinical Chemistry, 42, 515–523.

4. Contois, J., McNamara, J. R., Lammi-Keefe, C., Wilson, P. W., Massov, T., & Schaefer, E. J. (1996). Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clinical Chemistry, 42, 507–514.

5. Walldius, G., & Jungner, I. (2007). Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke. Current Opinion in Cardiology, 22, 359–367.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid profile, apolipoproteins A‐1 and B in owl monkeys ( Aotus infulatus ) in captivity;Journal of Medical Primatology;2022-08-02

2. Aged Monkeys Fed a High-Fat/High-Sugar Diet Recapitulate Metabolic Disorders and Cardiac Contractile Dysfunction;Journal of Cardiovascular Translational Research;2021-02-16

3. TMT-based proteomics analysis reveals the efficacy of jiangzhuo formula in improving the lipid profiles of dyslipidemia rats;Journal of Ethnopharmacology;2021-01

4. Human Bioengineered Artery Models for In Vitro Atherosclerosis Research: Fact or Fiction?;Alternatives to Laboratory Animals;2014-06

5. Quantification of Tau in Cerebrospinal Fluid by Immunoaffinity Enrichment and Tandem Mass Spectrometry;Clinical Chemistry;2014-04-01